Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

HF 1031

as introduced - 93rd Legislature (2023 - 2024) Posted on 02/27/2023 04:43pm

KEY: stricken = removed, old language.
underscored = added, new language.

Bill Text Versions

Introduction Posted on 01/27/2023

Current Version - as introduced

Line numbers 1.1 1.2 1.3 1.4 1.5
1.6 1.7 1.8 1.9 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 2.1 2.2 2.3 2.4 2.5 2.6 2.7 2.8 2.9 2.10 2.11 2.12 2.13 2.14 2.15

A bill for an act
relating to health occupations; modifying limitations on prescribing and
administering certain drugs by optometrists; amending Minnesota Statutes 2022,
section 148.56, subdivision 1.


Section 1.

Minnesota Statutes 2022, section 148.56, subdivision 1, is amended to read:

Subdivision 1.

Optometry defined.

(a) Any person shall be deemed to be practicing
optometry within the meaning of sections 148.52 to 148.62 who shall in any way:

(1) advertise as an optometrist;

(2) employ any means, including the use of autorefractors or other automated testing
devices, for the measurement of the powers of vision or the adaptation of lenses or prisms
for the aid thereof;

(3) possess testing appliances for the purpose of the measurement of the powers of vision;

(4) diagnose any disease, optical deficiency or deformity, or visual or muscular anomaly
of the visual system consisting of the human eye and its accessory or subordinate anatomical

(5) prescribe lenses, including plano or cosmetic contact lenses, or prisms for the
correction or the relief of same;

(6) employ or prescribe ocular exercises, orthoptics, or habilitative and rehabilitative
therapeutic vision care; or

(7) prescribe or administer legend drugs to aid in the diagnosis, cure, mitigation,
prevention, treatment, or management of disease, deficiency, deformity, or abnormality of
the human eye and adnexa included in the curricula of accredited schools or colleges of
optometry, and as limited by Minnesota statute and adopted rules by the Board of Optometry,
or who holds oneself out as being able to do so.

(b) In the course of treatment, nothing in this section shall allow:

(1) deleted text beginlegend drugs to be administered intravenously, intramuscularly, or by injection,
except for treatment of anaphylaxis
deleted text endnew text begin intravitreal injectionsnew text end;

(2) invasive surgery including, but not limited to, surgery using lasers;

(3) Schedule II and III oral legend drugs deleted text beginand oral steroidsdeleted text end to be administered or
prescribed;new text begin or
new text end

(4) oral deleted text beginantivirals to be prescribed or administered for more than ten days; ordeleted text endnew text begin steroids
to be prescribed or administered for more than 14 days without consultation with a physician.
new text end

deleted text begin (5) oral carbonic anhydrase inhibitors to be prescribed or administered for more than
seven days.
deleted text end